工作经历

时间	单位	职位
	中山医科大学肿瘤医院	内科主任

教育经历

时间	学校	专业	学位

荣誉及其他

序号	称号
1	95年被美国人物传记中心（ABI）授予“肿瘤内科学突出贡献奖”

发表文献

序号	文献名称(点击文献题目即可查看内容)	发表刊物	发表日期
1	A phase II study of gemcitabine plus paclitaxel in patients with metastatic breast cancer and prior anthracycline treatment	Asia Pac J Clin Oncol	2010
2	Association of phosphatase and tensin homolog low and phosphatidylinositol 3-kinase catalytic subunit alpha gene mutations on outcome in human epidermal growth factor receptor 2-positive metastatic breast cancer patients treated with first-line lapatinib plus paclitaxel or paclitaxel alone	Breast Cancer Res	2014
3	Randomized trial of lapatinib versus placebo added to paclitaxel in the treatment of human epidermal growth factor receptor 2-overexpressing metastatic breast cancer	J Clin Oncol	2013
4	; Safety and efficacy of first-line bevacizumab combined with taxane therapy in Chinese patients with HER2-negative locally recurrent or metastatic breast cancer: findings from the ATHENA study	Chin Med J (Engl)	2012
5	Chinese HER2 positive early breast cancer trastuzumab adjuvant therapy: preliminary outcomes]	Zhonghua Yi Xue Za Zhi	2012
6	Lamivudine prophylaxis reduces the incidence and severity of hepatitis in hepatitis B virus carriers who receive chemotherapy for lymphoma	Cancer	2006
7	Discordance of estrogen receptor (ER), progestin receptor (PR), and HER-2 receptor statuses between primary and metastatic focuses of breast cancer	Ai Zheng	2002
8	Phase II clinical study of topotecan hydrochloride in patients with recurrent advanced ovarian cancer	Zhonghua Zhong Liu Za Zhi	2006
9	Significance of EGFR and p-ERK expression in nasopharyngeal carcinoma	Amifostin in protection of kidney from cisplatinum injury	Zhonghua Zhong Liu Za Zhi

专利发明

序号	专利名称	专利号	批准日期
1	碘化－3，3＇－二乙基－9－甲基－硫杂羰花青的抗肿瘤新用途	CN1390544A	2003.01.15